Artificial intelligence is reshaping how we study cancer, turning routine pathology images into a source of deeper biological and clinical insight. On 11 May 2026, from 4 pm to 5 pm, Human Technopole will host a keynote lecture by Prof. Carlo Bifulco. The lecture will explore how pathology foundation models are advancing cancer research and precision oncology, with a focus on what can be learned from standard H&E slides. These AI-based approaches can help identify immune phenotypes, reveal biomarker associations and improve our understanding of how tumours respond to treatment.
The talk will also examine generative AI applications such as virtual staining, including the generation of virtual multiplex immunofluorescence from conventional tissue slides and spatial biology datasets. These methods make it possible to build population-scale maps of the tumour immune microenvironment, opening new ways to investigate tumour biology at scale. Prof. Bifulco will also present multimodal models that combine pathology, radiology and clinical data into integrated patient representations, with potential applications in predicting therapy response and matching patients to clinical trials.
Carlo Bifulco is Chief Pathologist at Providence Healthcare System, Chief Medical Officer at Providence Genomics and Medical Director of Precision Oncology at Providence Cancer Institute in Portland, Oregon, USA. His work brings together computational pathology, spatial biology and precision medicine.
The event, organised by the Centre for Innovation and Technology Transfer, is part of the MIND Innovation Week and it will be followed by a networking aperitivo.
Language: English
More information here: AI Applications of Large Biomedical Data – Human Technopole
